Niridazole
Star1
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Niridazole
- DrugBank Accession Number
- DB13661
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 214.2
Monoisotopic: 214.016061243 - Chemical Formula
- C6H6N4O3S
- Synonyms
- Niridazol
- Niridazole
- Niridazolum
- External IDs
- BA 32644
- BA 32644 Ciba
- CIBA 32644BA
- NSC-136947
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- ATC Codes
- P02BX02 — Niridazole
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as nitrothiazoles. These are compounds containing a thiazole ring which bears a nitro group.
- Kingdom
- Organic compounds
- Super Class
- Organoheterocyclic compounds
- Class
- Azoles
- Sub Class
- Thiazoles
- Direct Parent
- Nitrothiazoles
- Alternative Parents
- Nitroaromatic compounds / 2,5-disubstituted thiazoles / Imidazolidinones / Heteroaromatic compounds / Ureas / Propargyl-type 1,3-dipolar organic compounds / Organic oxoazanium compounds / Azacyclic compounds / Organopnictogen compounds / Organonitrogen compounds show 3 more
- Substituents
- 2,5-disubstituted 1,3-thiazole / Allyl-type 1,3-dipolar organic compound / Aromatic heteromonocyclic compound / Azacycle / C-nitro compound / Carbonic acid derivative / Carbonyl group / Heteroaromatic compound / Hydrocarbon derivative / Imidazolidine show 14 more
- Molecular Framework
- Aromatic heteromonocyclic compounds
- External Descriptors
- C-nitro compound, thiazoles (CHEBI:82349)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- N116U8Y5QQ
- CAS number
- 61-57-4
- InChI Key
- RDXLYGJSWZYTFJ-UHFFFAOYSA-N
- InChI
- InChI=1S/C6H6N4O3S/c11-5-7-1-2-9(5)6-8-3-4(14-6)10(12)13/h3H,1-2H2,(H,7,11)
- IUPAC Name
- 1-(5-nitro-1,3-thiazol-2-yl)imidazolidin-2-one
- SMILES
- [O-][N+](=O)C1=CN=C(S1)N1CCNC1=O
References
- General References
- Not Available
- External Links
- KEGG Compound
- C19268
- ChemSpider
- 5868
- ChEBI
- 82349
- ChEMBL
- CHEMBL152632
- ZINC
- ZINC000003875416
- Wikipedia
- Niridazole
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 2.21 mg/mL ALOGPS logP 0.3 ALOGPS logP 0.24 Chemaxon logS -2 ALOGPS pKa (Strongest Acidic) 15.52 Chemaxon pKa (Strongest Basic) -4.4 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 88.37 Å2 Chemaxon Rotatable Bond Count 2 Chemaxon Refractivity 45.8 m3·mol-1 Chemaxon Polarizability 18.6 Å3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 146.8622084 predictedDarkChem Lite v0.1.0 [M-H]- 134.71004 predictedDeepCCS 1.0 (2019) [M+H]+ 147.5476084 predictedDarkChem Lite v0.1.0 [M+H]+ 138.53737 predictedDeepCCS 1.0 (2019) [M+Na]+ 147.2055084 predictedDarkChem Lite v0.1.0 [M+Na]+ 147.84953 predictedDeepCCS 1.0 (2019)
Drug created at June 23, 2017 20:46 / Updated at February 21, 2021 18:54